Zinc oleate | 557-07-3

• 物质功能分类: 有机原料 - 有机金属盐
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Zinc oleate
• 英文别名: zinc;(Z)-octadec-9-enoate
• CAS: 557-07-3
• 化学式: C36H66O4Zn
• 分子量: 628.3
• InChiKey: LPEBYPDZMWMCLZ-CVBJKYQLSA-L

物化性质

• 熔点：
  70°C (rough estimate)
• 溶解度：
  不溶于水；溶于乙醇、乙醚、苯
• 物理描述：
  Liquid

计算性质

• 辛醇/水分配系数(LogP)：
  9.55
• 重原子数：
  41
• 可旋转键数：
  28
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  80.3
• 氢给体数：
  0
• 氢受体数：
  4

ADMET

代谢

锌可以通过肺部、皮肤和胃肠道进入人体。肠道对锌的吸收由锌载体蛋白CRIP控制。锌还与金属硫蛋白结合，帮助防止过量锌的吸收。锌广泛分布并在所有组织和组织液中找到，特别是在肝脏、胃肠道、肾脏、皮肤、肺、大脑、心脏和胰腺中。在血液中，锌存在于红细胞中的碳酸酐酶结合，以及血浆中的白蛋白、α2-巨球蛋白和氨基酸结合。白蛋白和氨基酸结合的锌可以扩散穿过组织膜。锌通过尿液和粪便排出体外。

Zinc can enter the body through the lungs, skin, and gastrointestinal tract. Intestinal absorption of zinc is controlled by zinc carrier protein CRIP. Zinc also binds to metallothioneins, which help prevent absorption of excess zinc. Zinc is widely distributed and found in all tissues and tissues fluids, concentrating in the liver, gastrointestinal tract, kidney, skin, lung, brain, heart, and pancreas. In the bloodstream zinc is found bound to carbonic anhydrase in erythrocytes, as well as bound to albumin, _2-macroglobulin, and amino acids in the the plasma. Albumin and amino acid bound zinc can diffuse across tissue membranes. Zinc is excreted in the urine and faeces. (L49)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 毒性总结

缺铁性贫血是由于锌的过度吸收抑制了铜和铁的吸收，这很可能是通过肠道粘膜细胞的竞争性结合实现的。铜和锌与铜锌超氧化物歧化酶结合的不平衡水平与肌萎缩侧索硬化症（ALS）有关。胃酸能溶解金属锌，生成腐蚀性的氯化锌，这可能会损伤胃粘膜。金属烟雾热被认为是对吸入锌的免疫反应。（L48, L49, A49）

Anaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc. (L48, L49, A49)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 致癌物分类

对人类不具有致癌性（未被国际癌症研究机构IARC列名）。

No indication of carcinogenicity to humans (not listed by IARC).

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 健康影响

长期接触锌会导致贫血、共济失调、乏力，并降低体内良好胆固醇的水平。还认为它会导致胰腺和生殖损伤。

Chronic exposure to zinc causes anemia, atazia, lethargy, and decreases the level of good cholesterol in the body. It is also believed to cause pancreatic and reproductive damage. (L49)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 暴露途径

口服（L49）；吸入（L49）；皮肤给药（L49）

Oral (L49) ; inhalation (L49) ; dermal (L49)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 症状

摄入大剂量的锌会导致胃痉挛、恶心和呕吐。急性吸入大量锌会引起金属烟雾热，其特征是寒战、发热、头痛、乏力、鼻和喉咙干燥、胸痛和咳嗽。锌与皮肤的接触会导致皮肤刺激。

Ingestion of large doses of zinc causes stomach cramps, nausea, and vomiting. Acute inhalation of large amounts of zinc causes metal fume fever, which is characterized by chills, fever, headache, weakness, dryness of the nose and throat, chest pain, and coughing. Dermal contact with zinc results in skin irritation. (L49)

来源:Toxin and Toxin Target Database (T3DB)

安全信息

• 包装等级：
  III
• 危险类别：
  9
• 危险性防范说明：
  P501,P273,P260,P270,P264,P280,P391,P314,P337+P313,P305+P351+P338,P301+P312+P330
• 危险品运输编号：
  3077
• 危险性描述：
  H302,H319,H372,H410

制备方法与用途

生产方法

可由油酸钾与硫酸锌通过复分解反应制得。

具体步骤如下：将油酸钾的乙醇溶液与稍过量的硫酸锌的水溶液混合，进行复分解反应，生成肥皂状的油酸锌沉淀。随后用水彻底洗涤，直至无硫酸根离子存在为止。再用少量乙醇洗去游离的酸。抽干后所得固体可用苯重结晶，然后在五氧化二磷存在下进行真空干燥，最终得到纯净的产品。

反应信息

• 作为产物：
  描述：

  Zinc Oxide 、 oleate 以 水 为溶剂， 以A total of 199.7 grams of product filtrate was obtained的产率得到Zinc oleate
  参考文献：
  名称：

  Organometallic compounds and compositions thereof with lubricants

  摘要：

  提供了聚芳胺硫化物和聚芳胺酚硫化物的金属化合物。所述化合物具有分散剂和润滑剂的作用，通过添加其中一个或多个化合物的性能改进量，可以使其稳定抗氧化，并改善其磨损保护性能。

  公开号：

  US04066561A1

文献信息

• ASYMMETRIC ORGANIC PEROXIDE, CROSSLINKING AGENT COMPRISING THE SAME, AND METHOD OF CROSSLINKING WITH THE SAME
  申请人：NOF CORPORATION

  公开号：EP1233014A1

  公开（公告）日：2002-08-21

  A crosslinking agent comprising an asymmetry organic peroxide having at least one structure unit of (substituted)benzoylcarbonyloxy group represented by the following formula (1) in the molecule thereof. Environmentally friendly crosslinking agents and crosslinked silicone rubber moldings are provided thereby. Specifically, useful crosslinking agents and crosslinking processes for silicone rubber are provided.

  一种交联剂，包括至少具有分子中表示为以下式（1）的（取代）苯甲酰羰氧基结构单元的不对称有机过氧化物。因此提供了环保的交联剂和交联硅橡胶成型品。具体提供了用于硅橡胶的有用交联剂和交联工艺。
• ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF
  申请人：Soll Mark David

  公开号：US20140080862A1

  公开（公告）日：2014-03-20

  The present invention relates to novel aryloazol-2-yl-cyanoethylamino derivatives of formula (I): wherein R 3 , R 4 , R 5 , R 6 , R 7 , P, Q, V, W, X, Y, Z and a are as defined in the description, compositions thereof, processes for their preparation and their uses as pesticides.

  本发明涉及新颖的式(I)的芳基咪唑-2-基-氰基乙基氨基衍生物：其中R3、R4、R5、R6、R7、P、Q、V、W、X、Y、Z和a如描述中所定义，以及其组合物、制备方法以及它们作为杀虫剂的用途。
• [EN] PHARMACEUTICAL COMPOSITIONS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES
  申请人：GENZYME CORP

  公开号：WO2009154747A1

  公开（公告）日：2009-12-23

  This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceutically acceptable composition includes, for example, crosslinked polyamine particles, or pharmaceutically acceptable salts thereof, having a particle size distribution wherein greater than 10 vol.% of the particles have a particle size greater than 500 μm.

  这项发明涉及交联胺含有聚合物用于结合化合物或离子，更具体地涉及用于结合化合物或离子的药用可接受组合物，其中包括交联胺含有聚合物。药用可接受组合物包括例如交联聚胺颗粒或其药用可接受盐，具有粒径分布，其中大于10体积%的颗粒具有大于500μm的粒径。
• 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
  申请人：Lee Ik Hyoung

  公开号：US20080031902A1

  公开（公告）日：2008-02-07

  Provided are 1-aryl-5-alkyl pyrazole compounds, of formula (I): wherein: R 1 is hydrogen, cyano, halogen, R 8 , formyl, —C(O)R 8 , —C(O)OR 8 , —C(O)NR 9 R 10 , or —C(S)NH 2 ; R 2 is R 2 or —S(O) m R 11 ; R 3 is methyl, ethyl or C 1 -C 4 haloalkyl; R 4 , R 5 and R 7 are independently hydrogen, halogen, alkyl, haloalkyl, cyano or nitro; R 6 is halogen, alkyl, haloalkyl, alkoxy, haloalkyloxy, cyano, nitro, —C(O)R 12 , —S(O) n R 12 or SF 5 ; Z is a nitrogen atom or C—R 13 ; R 8 is alkyl, haloalkyl, cycloalkyl or halocycloalkyl; R 9 is hydrogen, alkyl, haloalkyl or alkoxy; R 10 is hydrogen, alkyl, haloalkyl or alkoxy; R 11 is alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl or cycloalkyl; R 12 is alkyl or haloalkyl; R 13 is hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, alkoxy or haloalkoxy; m is 0, 1 or 2; and n is 0, 1 or 2; or a salt thereof, the method of making compounds of formula (I) and the use of these compounds against ectoparasites, endoparasites and pests.

  提供了1-芳基-5-烷基吡唑化合物，化学式为(I)：其中：R1为氢、氰基、卤素、R8、甲酰基、—C(O)R8、—C(O)OR8、—C(O)NR9R10或—C(S)NH2；R2为R2或—S(O)mR11；R3为甲基、乙基或C1-C4卤代烷基；R4、R5和R7独立地为氢、卤素、烷基、卤代烷基、氰基或硝基；R6为卤素、烷基、卤代烷基、烷氧基、卤代烷氧基、氰基、硝基、—C(O)R12、—S(O)nR12或SF5；Z为氮原子或C—R13；R8为烷基、卤代烷基、环烷基或卤代环烷基；R9为氢、烷基、卤代烷基或烷氧基；R10为氢、烷基、卤代烷基或烷氧基；R11为烷基、卤代烷基、烯基、卤代烯基、炔基、卤代炔基或环烷基；R12为烷基或卤代烷基；R13为氢、卤素、氰基、硝基、烷基、卤代烷基、烷氧基或卤代烷氧基；m为0、1或2；n为0、1或2；或其盐，制备化合物(I)的方法以及这些化合物对外寄生虫、内寄生虫和害虫的用途。
• Use of sulfur and selenium compounds as precursors to nanostructured materials
  申请人：THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

  公开号：US10253256B2

  公开（公告）日：2019-04-09

  The presently disclosed subject matter provides processes for preparing nanocrystals, including processes for preparing core-shell nanocrystals. The presently disclosed subject matter also provides sulfur and selenium compounds as precursors to nanostructured materials. The presently disclosed subject matter also provides nanocrystals having a particular particle size distribution.

  目前公开的主题提供了制备纳米晶体的过程，包括制备核壳纳米晶体的过程。目前公开的主题还提供硫和硒化合物作为纳米结构材料的前体。目前公开的主题还提供具有特定粒径分布的纳米晶体。